Search Results

There are 5594 results for: content related to: Randomized Study of Antihypertensive Efficacy and Safety of Combination Aliskiren/Valsartan vs Valsartan Monotherapy in Hypertensive Participants With Type 2 Diabetes Mellitus

  1. You have free access to this content
    Comparative Efficacy of Aliskiren/Valsartan vs Valsartan in Nocturnal Dipper and Nondipper Hypertensive Patients: A Pooled Analysis

    The Journal of Clinical Hypertension

    Volume 14, Issue 5, May 2012, Pages: 299–306, Thomas D. Giles, 1 Thomas Alessi, 2 Das Purkayastha and 2 Dion Zappe 2

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1751-7176.2012.00608.x

  2. You have free access to this content
    Aliskiren in the Treatment of Hypertension and Organ Damage

    Cardiovascular Therapeutics

    Volume 29, Issue 1, February 2011, Pages: 77–87, Graziano Riccioni

    Version of Record online : 25 NOV 2010, DOI: 10.1111/j.1755-5922.2010.00230.x

  3. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

    International Journal of Clinical Practice

    Volume 60, Issue 11, November 2006, Pages: 1343–1356, S. VAIDYANATHAN, J. VALENCIA, C. KEMP, C. ZHAO, C-M. YEH, M-N. BIZOT, J. DENOUEL, H. A. DIETERICH and W. P. DOLE

    Version of Record online : 11 OCT 2006, DOI: 10.1111/j.1742-1241.2006.01164.x

  4. Effects of Renin-Angiotensin-Aldosterone System Blockade on Chlorhexidine Gluconate-Induced Sclerosing Encapsulated Peritonitis in Rats

    Therapeutic Apheresis and Dialysis

    Volume 16, Issue 1, February 2012, Pages: 75–80, Gülay Koçak, Alper Azak, Hesna Müzeyyen Astarcı, Bülent Huddam, Gökhan Karaca, Mevlüt Çeri, Murat Can, Mehmet Sert and Murat Duranay

    Version of Record online : 17 JAN 2012, DOI: 10.1111/j.1744-9987.2011.01031.x

  5. You have free access to this content
    Safety and Tolerability of the Direct Renin Inhibitor Aliskiren in Combination With Angiotensin Receptor Blockers and Thiazide Diuretics: A Pooled Analysis of Clinical Experience of 12,942 Patients

    The Journal of Clinical Hypertension

    Volume 13, Issue 7, July 2011, Pages: 506–516, William B. White, Robert Bresalier, Allen P. Kaplan, Biff F. Palmer, Robert H. Riddell, Anastasia Lesogor, William Chang and Deborah L. Keefe

    Version of Record online : 18 MAR 2011, DOI: 10.1111/j.1751-7176.2011.00438.x

  6. You have free access to this content
    Combination Therapy With Various Combinations of Aliskiren, Valsartan, and Hydrochlorothiazide in Hypertensive Patients Not Adequately Responsive to Hydrochlorothiazide Alone

    The Journal of Clinical Hypertension

    Volume 11, Issue 6, June 2009, Pages: 324–332, Helmut Geiger, Elizabeth Barranco, Manuel Gorostidi, Addison Taylor, Xiaoli Zhang, Zhihua Xiang and Jack Zhang

    Version of Record online : 12 MAY 2009, DOI: 10.1111/j.1751-7176.2009.00114.x

  7. Blood pressure lowering efficacy of renin inhibitors for primary hypertension

    Intervention Review

    The Cochrane Library

    Vijaya M Musini, Kendra AK Lawrence, Patricia M Fortin, Ken Bassett and James M Wright

    Published Online : 5 APR 2017, DOI: 10.1002/14651858.CD007066.pub3

  8. Aliskiren: An Oral Direct Renin Inhibitor for the Treatment of Hypertension

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 2, February 2009, Pages: 193–212, Cynthia A. Sanoski

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.2.193

  9. You have free access to this content
    Posters

    The Journal of Clinical Hypertension

    Volume 12, Issue s1, April 2010, Pages: A18–A147,

    Version of Record online : 1 APR 2010, DOI: 10.1111/j.1751-7176.2010.00282.x

  10. You have full text access to this OnlineOpen article
    Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension

    The Journal of Clinical Hypertension

    Jack Ishak, Michael Rael, Henry Punzi, Alan Gradman, Lynn M. Anderson, Mehul Patel, Sanjida Ali, William Ferguson and Joel Neutel

    Version of Record online : 5 NOV 2017, DOI: 10.1111/jch.13132

  11. You have free access to this content
    Antihypertensive Drugs and Pharmacology

    The Journal of Clinical Hypertension

    Volume 9, Issue 5SA, May 2007, Pages: A149–A189,

    Version of Record online : 10 OCT 2011, DOI: 10.1111/j.1751-7176.2007.tb00065.x

  12. You have free access to this content
    Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 4, April 2012, Pages: 470–481, Azhar Rashikh, Shibli Jameel Ahmad, Krishna Kolappa Pillai and Abul Kalam Najmi

    Version of Record online : 7 DEC 2011, DOI: 10.1111/j.2042-7158.2011.01414.x

  13. You have free access to this content
    Effect of Add-on Aliskiren to Type 1 Angiotensin Receptor Blocker Therapy on Endothelial Function and Autonomic Nervous System in Hypertensive Patients With Ischemic Heart Disease

    The Journal of Clinical Hypertension

    Volume 16, Issue 8, August 2014, Pages: 591–598, Atsuko Ozeki, Eisuke Amiya, Masafumi Watanabe, Yumiko Hosoya, Munenori Takata, Aya Watanabe, Shuichi Kawarasaki, Tomoko Nakao, Shogo Watanabe, Kazuko Omori, Namie Yamada, Yukiko Tahara, Yasunobu Hirata and Ryozo Nagai

    Version of Record online : 7 JUL 2014, DOI: 10.1111/jch.12366

  14. RENIN INHIBITION WITH ALISKIREN

    Clinical and Experimental Pharmacology and Physiology

    Volume 35, Issue 4, April 2008, Pages: 426–430, Grégoire Wuerzner and Michel Azizi

    Version of Record online : 27 FEB 2008, DOI: 10.1111/j.1440-1681.2008.04890.x

  15. You have free access to this content
    Antihypertensive Drugs and Pharmacology

    The Journal of Clinical Hypertension

    Volume 10, Issue 5SA, May 2008, Pages: A6–A37,

    Version of Record online : 11 OCT 2011, DOI: 10.1111/j.1751-7176.2008.tb00041.x

  16. Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor—Neprilysin Inhibitor (ARNi)

    The Journal of Clinical Pharmacology

    Volume 50, Issue 4, April 2010, Pages: 401–414, Dr Jessie Gu, Dr Adele Noe, Dr Priya Chandra, Dr Suliman Al-Fayoumi, Dr Monica Ligueros-Saylan, Dr Ramesh Sarangapani, Dr Suzanne Maahs, Dr Gary Ksander, Dr Dean F. Rigel, Dr Arco Y. Jeng, Dr Tsu-Han Lin, Dr Weiyi Zheng and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009343932

  17. You have free access to this content
    Poster Abstracts

    The Journal of Clinical Hypertension

    Volume 11, Issue s1, April 2009, Pages: A16–A168,

    Version of Record online : 13 APR 2009, DOI: 10.1111/j.1751-7176.2009.00107.x

  18. You have full text access to this OnlineOpen article
    Dementia-related adverse events in PARADIGM-HF and other trials in heart failure with reduced ejection fraction

    European Journal of Heart Failure

    Volume 19, Issue 1, January 2017, Pages: 129–137, Jane A. Cannon, Li Shen, Pardeep S. Jhund, Søren L. Kristensen, Lars Køber, Fabian Chen, Jianjian Gong, Martin P. Lefkowitz, Jean L. Rouleau, Victor C. Shi, Karl Swedberg, Michael R. Zile, Scott D. Solomon, Milton Packer, John J.V. McMurray and on behalf of the PARADIGM-HF Investigators and Committees

    Version of Record online : 20 NOV 2016, DOI: 10.1002/ejhf.687

  19. Effect of valsartan on kidney outcomes in people with impaired glucose tolerance

    Diabetes, Obesity and Metabolism

    Volume 19, Issue 6, June 2017, Pages: 791–799, Gemma Currie, M. Angelyn Bethel, Björn Holzhauer, Steven M. Haffner, Rury R. Holman and John J. V. McMurray

    Version of Record online : 17 MAR 2017, DOI: 10.1111/dom.12877

  20. Hypertension

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt074